Globe Life (NYSE:GL) Issues FY 2025 Earnings Guidance

Globe Life (NYSE:GL) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 13.450-14.050 for the period, compared to the consensus EPS estimate of 13.580. The company issued revenue guidance of -.

Wall Street Analyst Weigh In

Several brokerages have commented on GL. BMO Capital Markets initiated coverage on Globe Life in a research report on Thursday, January 23rd. They set a “market perform” rating and a $114.00 price objective for the company. Truist Financial raised their price objective on Globe Life from $90.00 to $105.00 and gave the company a “hold” rating in a research note on Friday, October 25th. Keefe, Bruyette & Woods boosted their target price on shares of Globe Life from $135.00 to $137.00 and gave the company an “outperform” rating in a research note on Friday, January 10th. Piper Sandler lifted their price target on shares of Globe Life from $118.00 to $130.00 and gave the stock an “overweight” rating in a report on Friday, October 25th. Finally, Evercore ISI raised Globe Life from an “in-line” rating to an “outperform” rating and boosted their price target for the company from $132.00 to $143.00 in a report on Wednesday, January 8th. Five investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Globe Life currently has an average rating of “Moderate Buy” and a consensus price target of $132.18.

Globe Life Stock Performance

NYSE GL traded up $2.57 during midday trading on Friday, hitting $122.54. The company had a trading volume of 255,215 shares, compared to its average volume of 552,016. The stock has a market cap of $10.29 billion, a price-to-earnings ratio of 10.35 and a beta of 0.81. Globe Life has a fifty-two week low of $38.95 and a fifty-two week high of $132.00. The firm has a fifty day simple moving average of $112.95 and a two-hundred day simple moving average of $106.62. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.50.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, February 5th. The company reported $3.14 EPS for the quarter, beating analysts’ consensus estimates of $3.12 by $0.02. Globe Life had a net margin of 19.04% and a return on equity of 22.91%. Equities analysts forecast that Globe Life will post 12.32 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Monday, January 6th were given a dividend of $0.24 per share. The ex-dividend date of this dividend was Monday, January 6th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.78%. Globe Life’s payout ratio is presently 8.12%.

Insiders Place Their Bets

In other news, Director Mark A. Blinn sold 3,000 shares of Globe Life stock in a transaction on Monday, January 6th. The stock was sold at an average price of $113.23, for a total transaction of $339,690.00. Following the sale, the director now directly owns 5,122 shares in the company, valued at $579,964.06. The trade was a 36.94 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Frank M. Svoboda sold 13,448 shares of the company’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $112.56, for a total value of $1,513,706.88. Following the completion of the transaction, the chief executive officer now owns 18,948 shares in the company, valued at approximately $2,132,786.88. The trade was a 41.51 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 39,788 shares of company stock worth $4,429,779 over the last ninety days. Corporate insiders own 1.51% of the company’s stock.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.